CVS Health Q1 2024 Adj EPS $1.31 Misses $1.69 Estimate, Sales $88.437B Miss $89.209B Estimate
Portfolio Pulse from Benzinga Newsdesk
CVS Health reported Q1 2024 adjusted EPS of $1.31, missing the $1.69 estimate, and sales of $88.437B, missing the $89.209B estimate. This represents a 40.45% decrease in EPS and a 3.70% increase in sales from the same period last year.
May 01, 2024 | 10:31 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
CVS Health's Q1 2024 earnings and sales missed estimates, with a significant decrease in EPS compared to last year.
Missing both EPS and sales estimates, especially with a significant year-over-year decrease in EPS, is likely to negatively impact investor sentiment and could lead to a short-term decrease in CVS Health's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100